We are a technology company operating in the field of healthcare. Our innovative solutions are revolutionizing the ways lives can be saved and patients can be treated.
We develop technologies to support diagnostic imaging and next-generation digital medicine. We are continually expanding our portfolio of services to match the needs of a changing world and to explore new areas of application.
CarnaLife Holo is a breakthrough technology for 3D visualization of imaged medical data, supporting the planning and execution of medical procedures.Read More
A breakthrough tool for remote 3D product demonstration, perfect for medicine and industry.Read More
Innovative solution for in-depth, remote patient diagnostics in combination with e-consultation.Read More
Modern software for medical consultations, diagnostics and in-depth health monitoring.Read More
We are experts in technology for medicine. We combine the knowledge and experience of engineers, programmers, physicians and scientists.
We offer unique software solutions to support diagnostic imaging, next generation digital medicine services and business.
Continuous improvement of the quality of diagnoses and continuous development through the use of modern IT tools
Mixed reality (MR) and augmented reality (AR) technologies to improve diagnosis and treatment
BIG DATA ANALYSIS
Analysis of aggregated data using multiple peripherals and their handling in an innovative telemedicine system
Our cooperation with international leaders in technology and medicine enables us to safely collect, analyse and visualise unlimited amount of medical data. As a result, our solutions are indispensable in variety of medical applications.
Using the secure Azure cloud to store medical data
Significant substantive support for MedApp’s proprietary CarnaLife Holo and HoloComm projects
Use of Microsoft HoloLens 2
Microsoft Teams Integration - Secure Doctor-Patient Communication
Collaborative design for real-time transmission and visualization of data from Vivid E 95 echocardiographers
A collaborative project to screen cardiology patients for arrhythmias
Project conducted on nearly 2,000 patients
Satisfaction of our partners is the foundation of our work. We strive to make sure that our solutions make a real difference to physicians and the treatment process.
The goal of the Kardiosystem clinic is to ensure that our Patients have access to the most modern treatment methods for heart diseases. The CarnaLife System application, offered by MedApp S.A. supports our activities in this area, providing unique opportunities to combine medical consultations with remote ECG measurement, performed at a time and place convenient for the Patient. Thanks to this cooperation, we have expanded our offer, improved the work of doctors and reinforced the sense of security of Patients.
At NEO Hospital , innovative Carna Life Holo technology is used to perform oncologic treatments for unresectable primary liver tumors and metastatic tumors. CarnaLife Holo allows the surgeon to accurately image and locate lesions, which affects the safety of the procedure, the ability to perform it in a short amount of time, and to perform a targeted procedure. NEO Hospital is also using CarnaLife Holo’s 3D visualization of imaging medical data for a research and development project in gynecologic oncology. Within the project, CarnaLife Holo supports treatment planning. The hologram makes visible the complex spatial relationships between anatomical structures, which is extremely important when planning oncology treatments. The innovative CarnaLife System is also used by the Obesity Clinic at NEO Hospital to record medical data for efficient collection and analysis. The measurements collected and analyzed by CarnaLife System can be used by metabolic surgery specialists, cardiologists, pulmonologists, diabetologists, and physicians of other specialties. We appreciate the innovation and effectiveness of solutions prepared by MedApp S.A. We are also pleased with the ongoing collaboration, support and service offered by the MedApp S.A. team.
President of the Board of Neo Hospital
This project has received from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 956470
design by fluostudio